Elisabetta Magrini

Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer

Federico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli et al. · JNCI Journal of the National Cancer Institute · 2004 · 367 citations · Full text

Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC

Federico Cappuzzo, Vanesa Gregorc, Elisa Rossi et al. · Journal of Clinical Oncology · 2003 · 213 citations

Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial

Federico Cappuzzo, Claudia Ligorio, Pasi A. Jänne et al. · Journal of Clinical Oncology · 2007 · 211 citations

Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib

Federico Cappuzzo, Luca Toschi, Giovanni Tallini et al. · Annals of Oncology · 2006 · 97 citations · Full text

Medicine, Pathology, Bronchial Neoplasm +6

In vitro testing of the potential for orthopedic bone cements to cause apoptosis of osteoblast-like cells

G. Ciapetti, Donatella Granchi, L. Savarino et al. · Biomaterials · 2002 · 85 citations

Regenerative Medicine, Tissue Engineering, Vitro Testing +11